SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-119480
Filing Date
2015-04-06
Accepted
2015-04-06 08:41:01
Documents
9
Period of Report
2015-04-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d903476d8k.htm 8-K 27375
2 EX-99.1 d903476dex991.htm EX-99.1 456705
3 EX-99.2 d903476dex992.htm EX-99.2 551399
4 EX-99.3 d903476dex993.htm EX-99.3 797310
5 EX-99.4 d903476dex994.htm EX-99.4 12466
6 GRAPHIC g903476ex99_4.jpg GRAPHIC 2959
7 GRAPHIC g903476g24w40.jpg GRAPHIC 57691
8 GRAPHIC g903476g41j58.jpg GRAPHIC 53601
9 GRAPHIC g903476g69k50.jpg GRAPHIC 17300
  Complete submission text file 0001193125-15-119480.txt   2028151
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 15752524
SIC: 2834 Pharmaceutical Preparations